Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- N/A.
M&A news:
- BGC +32.3% (to be acquired by Prysmian Group for $30.00 per share)
- AET +3.2% (confirms acquisition by CVS Health (CVS) in transaction worth $207 per share)
- HIG +2.8% (to sell Talcott Resolution, its run-off life and annuity businesses, to a group of investors, for total consideration of $2.05 bln)
Other news:
- DPW +37.2% (subsidiary Coolisys technologies unveils cryptocurrency hardware)
- PXS +19.3% (continued volatility during pre-mkt)
- XNET +18.1% (continued volatility during pre-mkt)
- ZYNE +11% (presents new clinical data ZYN002 from STAR 1 and STAR 2 Studies)
- EGBN +10.1% (denies allegations from short seller report)
- CRNT +10.1% (receives $66 Million in orders for its IP-20 Platform from a tier 1 operator in India)
- MDGS +9.5% (continued volatility during pre-mkt)
- MARA +5.7% (continued volatility during pre-mkt)
- MBRX +5.1% (informed that the physician-sponsored IND application made by MD Anderson Cancer Center for a Phase I trial of the Company's licensed drug compound WP1066)
- RARE +4.4% (positive 48-week data from the randomized, double-blind, placebo-controlled Phase 3 study of burosumab )
- DGLY +4.2% (announced that the USPO rejected the request of Enforcement Video to institute an inter partes review on U.S. Patent No. 9,325,950)
- BLRX +3.6% (announces 'positive' overall survival data from the long-term follow-up part of the Phase 2a trial of BL-8040)
- OSTK +3.1% (continued volatility during pre-mkt)
- INFY +2.9% (appoints Salil Parekh as Chief Executive Officer)
- ZGNX +2.6% (announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008)
- BTX +2.3% (presents additional data from Renevia trial), GNC +2% (withdraws proposed offering of senior secured notes, retains Goldman Sachs to review alternatives to optimize its capital structure)
- MYL +1.3% (Mylan N.V. and Aspen (APNHY) launch Myleran)
- PYPL +1% (provides update on the suspension of operations of TIO Networks)
Analyst comments:
- APRN +6.8% (upgraded to Equal Weight from Underweight at Barclays)
- APLS +3.4% (initiated with a Overweight at JP Morgan, among others)
- EBAY +2.6% (upgraded to Outperform from Market Perform at BMO Capital)
- UPS +2.1% (upgraded to Buy from Hold at Deutsche Bank)
- PANW +1.9% (upgraded to Outperform from Mkt Perform at William Blair)
- ESRX +1.7% (initiated with a Buy at Deutsche Bank)